UMIN ID: UMIN000002339
Registered date:14/08/2009
Pharmacogenomics and pharmacokinetics study of drug metabolizing enzyme in patients with severe adverse drug reaction due to anti-neoplastics
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Cancer |
| Date of first enrollment | 2009/08/01 |
| Target sample size | 10 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Genetic polymorphism drug or metabolite concentration |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Informed consent not obtained |
Related Information
| Primary Sponsor | Graduate Schhol of Medicine Kyoto University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Ministry of Education, Culture, Sports, Science and Technology |
| Secondary ID(s) | G-309 |
Contact
| public contact | |
| Name | Hiroshi Ishiguro |
| Address | 54 Syogoinkawahara-cho, Sakyo-ku, Kyoto-city Japan |
| Telephone | 075-751-4950 |
| hkkishi@kuhp.kyoto-u.ac.jp | |
| Affiliation | Graduate Schhol of Medicine Kyoto University Department of Target Therapy Oncology |
| scientific contact | |
| Name | Hiroshi Ishiguro |
| Address | 54 Syogoinkawahara-cho, Sakyo-ku, Kyoto-city Japan |
| Telephone | 075-751-4950 |
| hkkishi@kuhp.kyoto-u.ac.jp | |
| Affiliation | Graduate Schhol of Medicine Kyoto University Department of Target Therapy Oncology |